Earnings
TJX Posts Strong Q3 Results and Raises Full-Year Targets
TJX posted Q3 EPS of $1.28 on $15.1 billion in revenue, beating expectations and prompting the company to raise its FY26 guidance.
BTC$64,470.00+1.55%
ETH$1,682.40+1.24%
USDT$0.9996+0.01%
USDC$0.9998+0.00%
XRP$1.15+1.82%
SOL$68.93+3.60%
TRX$0.3169+0.50%
FIGR_HELOC$1.02-1.53%
DOGE$0.0878+1.91%
HYPE$60.31-0.07%
USDS$0.9998+0.02%
LEO$9.73+0.30%
RAIN$0.013-0.19%
ZEC$422.21+3.66%
ADA$0.1719+1.57%
BTC$64,470.00+1.55%
ETH$1,682.40+1.24%
USDT$0.9996+0.01%
USDC$0.9998+0.00%
XRP$1.15+1.82%
SOL$68.93+3.60%
TRX$0.3169+0.50%
FIGR_HELOC$1.02-1.53%
DOGE$0.0878+1.91%
HYPE$60.31-0.07%
USDS$0.9998+0.02%
LEO$9.73+0.30%
RAIN$0.013-0.19%
ZEC$422.21+3.66%
ADA$0.1719+1.57%
TJX, Lowe’s, and United Therapeutics reported quarterly results that topped expectations, highlighting steady growth across retail and biotech.
TJX posted Q3 EPS of $1.28 on $15.1 billion in revenue, beating expectations and prompting the company to raise its FY26 guidance.
The TJX Companies, Inc. (NYSE: TJX) reported net sales of $16.4 billion for the fourth quarter of Fiscal 2025.
The TJX Companies, Inc. (NYSE: TJX) reported a robust performance for the third quarter of Fiscal Year 2025.
TJX reported an EPS of $1.03 and revenue of $13.3 billion for the third quarter.